RRx-001 – 5 mg

Brand:
Cayman
CAS:
925206-65-1
Storage:
-20
UN-No:
Non-Hazardous - /

RRx-001 is an anticancer agent.{49432} It inhibits growth in a panel of 12 cancer cell lines (IC50s =1.8-6 μM), an effect that is enhanced in SCC VII cells under hypoxic conditions. RRx-001 increases intracellular levels of reactive oxygen species (ROS) in HT-29 and SCC VII cells in a concentration- and time-dependent manner and induces apoptosis in SCC VII, HL-60, and Daudi cells when used at concentrations of 5, 5, and 4 μM, respectively. RRx-001 (5 mg/kg per day for five days) reduces tumor growth and enhances radiation-induced tumor growth reduction in an SCC VII murine squamous cell carcinoma model. Pre-incubation of red blood cells and hemolysate with RRx-001 (3 mM) increases nitrite-induced nitric oxide (NO) release under hypoxic conditions.{49433} RRx-001 (10 mg/kg) also decreases parasitemia and increases survival in a mouse model of P. berghei ANKA infection.{49434}  

 

Available on backorder

SKU: 28846 - 5 mg Category:

Description

An anticancer agent; inhibits growth in a panel of 12 cancer cell lines (IC50s = 1.8-6 μM), an effect that is enhanced in SCC VII cells under hypoxic conditions; increases intracellular ROS levels in HT-29 and SCC VII cells; induces apoptosis in SCC VII, HL-60, and Daudi cells at 5, 5, and 4 μM, respectively; reduces tumor growth and enhances radiation-induced tumor growth reduction in an SCC VII murine squamous cell carcinoma model at 5 mg/kg per day for five days; pre-incubation of red blood cells and hemolysate at 3 mM increases nitrite-induced NO release under hypoxic conditions; decreases parasitemia and increases survival in a mouse model of P. berghei ANKA infection at 10 mg/kg


Formal name: 2-bromo-1-(3,3-dinitro-1-azetidinyl)-ethanone

Synonyms:  ABDNAZ

Molecular weight: 268

CAS: 925206-65-1

Purity: ≥95%

Formulation: A solid